<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bokov DO</style></author><author><style face="normal" font="default" size="100%">Krasikova MK</style></author><author><style face="normal" font="default" size="100%">Sergunova EV</style></author><author><style face="normal" font="default" size="100%">Bobkova NV</style></author><author><style face="normal" font="default" size="100%">Kovaleva TYu</style></author><author><style face="normal" font="default" size="100%">Bondar AA</style></author><author><style face="normal" font="default" size="100%">Marakhova AI</style></author><author><style face="normal" font="default" size="100%">Morokhina SL</style></author><author><style face="normal" font="default" size="100%">Krasnyuk II</style></author><author><style face="normal" font="default" size="100%">Moiseev DV</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Pharmacognostic, Phytochemical and Ethnopharmacological Potential of Cyclamen coum Mill</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Coumoside A</style></keyword><keyword><style  face="normal" font="default" size="100%">Coumoside B</style></keyword><keyword><style  face="normal" font="default" size="100%">Cyclacumin</style></keyword><keyword><style  face="normal" font="default" size="100%">Cyclamen coum</style></keyword><keyword><style  face="normal" font="default" size="100%">Cyclaminorin</style></keyword><keyword><style  face="normal" font="default" size="100%">Deglucocyclamine</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">February  2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">204-212</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; This review focuses on characterization of &lt;em&gt;Cyclamen coum &lt;/em&gt;Mill. (&lt;em&gt;Myrsinaceae&lt;/em&gt;), composition and content of biologically active substances presented in the above-ground and underground parts, reporting use of this plant in traditional medicine, predicting possible pharmacotherapeutic effects. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; Various electronic search engines such as Google, Google scholar, scientific literature, electronic databases such as e-Library, Scopus, Web of Science, Pubmed had been searched and data obtained. &lt;strong&gt;Results:&lt;/strong&gt; &lt;em&gt;Cyclamen &lt;/em&gt;L. is classified in the &lt;em&gt;Myrsinaceae&lt;/em&gt; family now. It is a typical element of the Mediterranean flora. C. coum. is a species characteristic of the Caucasus and Crimea with rounded leaves and rounded corolla lobes, bright and pink-purple flowers. Chemical composition of biologically active substances of&lt;em&gt; C. coum&lt;/em&gt; was described in sufficient detail. &lt;em&gt;C. coum&lt;/em&gt; contains saponins (coumoside A, coumoside B, cyclaminorin, deglucocyclamin, cyclacoumin, and mirabilin lactone), sterols (stigmasterol and other related compounds), piperidine alkaloid (2-β-D-glycopyranosyl-2-undecil-3,5-dihydroxy-6-carboxypiperidine), flavonoids, phenols, tannins, cardiac glycosides. Antioxidant, antibacterial, antifungal, and antitumor activities are established for different &lt;em&gt;C. coum&lt;/em&gt; extracts. &lt;strong&gt;Conclusion:&lt;/strong&gt; &lt;em&gt;C. coum &lt;/em&gt;can be used for the production of potential anticancer, antibacterial and antifungal drugs. It should be noted that more pharmacognostic, pharmacological studies are needed for providing further information to use this medicinal plant in the official medicine. Also, standardization procedures for a crude herbal drug should be developed.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">204</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Bokov DO&lt;sup&gt;1,2,&lt;/sup&gt;*,#, Krasikova MK&lt;sup&gt;1,&lt;/sup&gt;#, Sergunova EV&lt;sup&gt;1&lt;/sup&gt;, Bobkova NV&lt;sup&gt;1&lt;/sup&gt;, Kovaleva TYu&lt;sup&gt;1&lt;/sup&gt;, Bondar AA&lt;sup&gt;1&lt;/sup&gt;, Marakhova AI&lt;sup&gt;3&lt;/sup&gt;, Morokhina SL&lt;sup&gt;4&lt;/sup&gt;, Krasnyuk II&lt;sup&gt;1&lt;/sup&gt;, Moiseev DV&lt;sup&gt;5&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Institute of Pharmacy, Sechenov First Moscow State Medical University, 8 Trubetskaya St., bldg. 2, Moscow, 119991, RUSSIAN FEDERATION.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Laboratory of Food Chemistry, Federal Research Center for Nutrition, Biotechnology and Food Safety, 2/14 Ustyinsky pr., Moscow, 109240, RUSSIAN FEDERATION.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Institute of Biochemical Technology and Nanotechnology, Рeoples’ Friendship University of Russia (RUDN University), 6, Miklukho-Maklaya Street, Moscow, 117198, RUSSIAN FEDERATION.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Preparatory faculty, Financial University under the Government of the Russian Federation (Financial University), 55, Leningradsky Prospekt, Moscow, 125057, RUSSIAN FEDERATION.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Chair of Standardization of Medicines, Vitebsk State Medical University, 27, Frunze avenue, Vitebsk, 210062, BELARUS #Bokov DO, Krasikova MK contributed equally to this work.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bokov DO</style></author><author><style face="normal" font="default" size="100%">Karabeshkin DI</style></author><author><style face="normal" font="default" size="100%">Samylina IA</style></author><author><style face="normal" font="default" size="100%">Potanina OG</style></author><author><style face="normal" font="default" size="100%">Krasnyuk II</style></author><author><style face="normal" font="default" size="100%">Malinkin AD</style></author><author><style face="normal" font="default" size="100%">Sergunova EV</style></author><author><style face="normal" font="default" size="100%">Kovaleva TYu</style></author><author><style face="normal" font="default" size="100%">Bobkova NV</style></author><author><style face="normal" font="default" size="100%">Antsyshkina AM</style></author><author><style face="normal" font="default" size="100%">Bondar AA</style></author><author><style face="normal" font="default" size="100%">Evgrafov AA</style></author><author><style face="normal" font="default" size="100%">Galiakhmetova EK</style></author><author><style face="normal" font="default" size="100%">Moiseev DV</style></author><author><style face="normal" font="default" size="100%">Bessonov VV</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Pharmacopoeial Analysis of Inulin-Containing Medicinal Plant Raw Materials and Drugs</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Fructosans</style></keyword><keyword><style  face="normal" font="default" size="100%">HPLC-RID</style></keyword><keyword><style  face="normal" font="default" size="100%">Inulin quantitative determination</style></keyword><keyword><style  face="normal" font="default" size="100%">Polyfructans</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">March 2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">415-421</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Today, there are some unresolved issues and discussions concerning inulin quantitative determination in medicinal plant raw materials (MPRM). MPRM containing polyfructans or fructosans (inulin and others) are rather complex multicomponent matrixes with many interacting compounds. The article discusses the prospects for further standardization of inulin-containing pharmacopoeial MPRM that include, in addition to polysaccharides (inulin), other biologically active compounds with pharmacological activity. &lt;strong&gt;Materials and Methods: &lt;/strong&gt;Different types of search tools such as Google scholar, Google, scientific literature, normative documentation of Russian Federation (State Pharmacopoeia of Russian Federation IV edition and others) electronic databases such as e-Library, Scopus, Web of Science, Pubmed had been searched and data obtained. &lt;strong&gt;Results: &lt;/strong&gt;The pharmacopoeial spectrophotometric procedures of inulin determination in the Russian Federation are approved in a version that does not fully satisfy modern standardization criteria. Regulatory changes required in the near future. &lt;strong&gt;Conclusion: &lt;/strong&gt;Undoubtedly, to determine inulin quantitatively, it is necessary to modify the existing spectrophotometric procedures and introduce an additional alternative, more specific HPLC-RID (or similar) ones.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Review Article </style></work-type><section><style face="normal" font="default" size="100%">415</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Bokov DO1,2,&lt;sup&gt;*,#&lt;/sup&gt;, Karabeshkin DI&lt;sup&gt;3,#&lt;/sup&gt;, Samylina IA&lt;sup&gt;1&lt;/sup&gt;, Potanina OG&lt;sup&gt;4&lt;/sup&gt;, Krasnyuk II&lt;sup&gt;1&lt;/sup&gt; (junior), Malinkin AD&lt;sup&gt;2&lt;/sup&gt;, Sergunova EV&lt;sup&gt;1&lt;/sup&gt;, Kovaleva TYu&lt;sup&gt;1&lt;/sup&gt;, Bobkova NV&lt;sup&gt;1&lt;/sup&gt;, Antsyshkina AM&lt;sup&gt;1&lt;/sup&gt;, Bondar AA&lt;sup&gt;1&lt;/sup&gt;, Evgrafov AA&lt;sup&gt;1&lt;/sup&gt;, Galiakhmetova EK&lt;sup&gt;5&lt;/sup&gt;, Moiseev DV&lt;sup&gt;6&lt;/sup&gt;, Bessonov VV&lt;sup&gt;2&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Institute of Pharmacy, Sechenov First Moscow State Medical University, 8 Trubetskaya St., bldg. 2, Moscow, 119991, RUSSIAN FEDERATION.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Laboratory of Food Chemistry, Federal Research Center of Nutrition, Biotechnology and Food Safety, 2/14 Ustyinsky pr., Moscow, 109240, RUSSIAN FEDERATION.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Normal physiology department, Northern State Medical University, 51Troitsky pr., 163000, Arkhangelsk, RUSSIAN FEDERATION.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Pharmaceutical chemistry and pharmacognosy chair, Рeoples’ Friendship University of Russia (RUDN University), 6, Miklukho-Maklaya Street, Moscow, 117198, RUSSIAN FEDERATION.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Department of pharmacognosy with a course in botany and the basics of herbal medicine, Bashkir state medical University, 3, Lenina str., Ufa, 450008, RUSSIAN FEDERATION.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Chair of Standardization of Medicines, Vitebsk State Medical University, 27, Frunze avenue, Vitebsk, 210062, BELARUS.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;#&lt;/sup&gt;Contributed equally to this work.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Guseinov MD</style></author><author><style face="normal" font="default" size="100%">Bobkova NV</style></author><author><style face="normal" font="default" size="100%">Svistunov AA</style></author><author><style face="normal" font="default" size="100%">Tarasov VV</style></author><author><style face="normal" font="default" size="100%">Bokov DO</style></author><author><style face="normal" font="default" size="100%">Sergunova EV</style></author><author><style face="normal" font="default" size="100%">Kovaleva TYu</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Flavonoids in Passiflora incarnata L. Dry Extract of Russian Origin</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Dry extract</style></keyword><keyword><style  face="normal" font="default" size="100%">Flavonoids</style></keyword><keyword><style  face="normal" font="default" size="100%">Passiflora incarnata</style></keyword><keyword><style  face="normal" font="default" size="100%">standardization</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">September 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">1143-1147</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Flavonoids are one of the main classes of biologically active substances providing the pharmacotherapeutic effect of passionflower (&lt;em&gt;Passiflora incarnata&lt;/em&gt; L.) preparations. In this article studies on the standardization of &lt;em&gt;Passiflora incarnata&lt;/em&gt; L. dry extract (PDE) by flavonoids are presented. The aim of this work was to study the composition and content of flavonoids in PDE with the help of precise modern physicochemical methods. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; PDE was prepared from crude herbal drug – &lt;em&gt;P. incarnata&lt;/em&gt; herb of Russian origin. Reverse phase HPLC-UV analysis was performed with Agilent 1100 liquid chromatograph. Chromatographic column was Atlantis C&lt;sub&gt;18&lt;/sub&gt; (250 mm × 4.6 mm × 5 μm); analytical wavelength – 350 nm; mobile phase – 0.01% formic acid solution and methanol: acetonitrile (25:75); column temperature – 35°C; analysis time – 90 min; flow rate of the mobile phase – 0.8 ml/min in gradient elution mode. Commercially available samples of flavonoids were used for identification and quantitative determination. &lt;strong&gt;Results: &lt;/strong&gt;20 compounds of flavonoid structure are presented in the PDE. 9 flavonoid compounds have been identified, they are: isovitexin, vitexin, rutoside, hyperoside, luteolin, kaempferol, kaempferitrin, orientin, and isoorientin. The content of vitexin is 0,867 ± 0,011%, the total flavonoids content in terms of vitexin is 3,762 ± 0,049%. &lt;strong&gt;Conclusion: &lt;/strong&gt;The obtained data will be used to create regulatory documentation for drugs based on PDE.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1143</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Guseinov MD&lt;sup&gt;1&lt;/sup&gt;, Bobkova NV&lt;sup&gt;2&lt;/sup&gt;, Svistunov AA&lt;sup&gt;2&lt;/sup&gt;, Tarasov VV&lt;sup&gt;2&lt;/sup&gt;, Bokov DO&lt;sup&gt;2,3,&lt;/sup&gt;*, Sergunova EV&lt;sup&gt;2&lt;/sup&gt;, Kovaleva TYu&lt;sup&gt;2 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Medical College named after Bashlarov, Amet Khan Sultan Ave., 10th km., 367915, Makhachkala, Republic of Dagestan, RUSSIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Sechenov First Moscow State Medical University, 8 Trubetskaya St., bldg. 2, 119991, RUSSIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;3&lt;/sup&gt;Federal Research Center for Nutrition, Biotechnology and Food Safety, 2/14, Ustyinsky pr., Moscow, 109240, RUSSIA.&lt;/p&gt;
</style></auth-address></record></records></xml>